1
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T27670 | JNJ-26076713 | JNJ26076713 | |
JNJ-26076713, an orally active alpha V integrin antagonist, represents a potential therapeutic candidate for the treatment of macular edema, age-related macular degeneration, and proliferative diabetic retinopathy. |